Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SANA

SANA News

Newswire

10:48

Sana Biotechnology shares surge 11.19% intraday as CEO Steve Harr highlights pipeline strategies and upcoming 2025 clinical data for SC291CD19 CAR T therapy.

02:16

Unpacking Sana Biotechnology's Pipeline Priorities: A Guide to Diabetes and Autoimmune Innovation

10:12

Autologous cell therapy market surpasses $10.1 billion in 2025, fueled by gene editing and biotech advancements.

19:33

Sana Biotechnology's Improved Efficiency: A Step Forward, but Risks Remain

13:17

Sana Biotechnology Maintains Buy Recommendation from HC Wainwright & Co. with 105.08% Upside Potential

View More

About SANA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More